Ubs Group Ag Nexgel, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Nexgel, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2 shares of NXGL stock, worth $5. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.12 - $3.01 $4 - $6	2 New	2 $0
Q3 2024 Nov 14, 2024	BUY	$2.04 - $3.19 $5,597 - $8,753	2,744 New	2,744 $7,000
Q1 2024 May 13, 2024	SELL	$1.99 - $2.96 $91 - $136	-46 Reduced 29.68%	109 $0
Q4 2023 Feb 09, 2024	BUY	$1.5 - $2.35 $232 - $364	155 New	155 $0
Q2 2023 Aug 11, 2023	BUY	$1.38 - $2.92 $6,800 - $14,389	4,928 Added 725.77%	5,607 $14,000
Q1 2023 May 12, 2023	SELL	$1.28 - $1.71 $5,680 - $7,588	-4,438 Reduced 86.73%	679 $0
Q4 2022 Feb 08, 2023	SELL	$1.17 - $1.66 $5,748 - $8,155	-4,913 Reduced 48.98%	5,117 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.25 - $1.98 $1,923 - $15,230	7,692 Added 329.0%	10,030 $15,000
Q2 2022 Aug 10, 2022	SELL	$1.4 - $1.98 $1,617 - $2,286	-1,155 Reduced 33.07%	2,338 $4,000
Q1 2022 May 16, 2022	SELL	$1.7 - $3.28 $2,619 - $5,054	-1,541 Reduced 30.61%	3,493 $7,000
Q4 2021 Feb 14, 2022	BUY	$2.61 - $3.52 $13,138 - $17,719	5,034 New	5,034 $13,000

Others Institutions Holding NXGL

# of Institutions

Shares Held

721K

Call Options Held

Put Options Held

Evernest Financial Advisors, LLC Carmel, IN

281K
Shares

$741,840
0.26% of portfolio
Morgan Stanley New York, NY

122K
Shares

$320,902
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

68.7K
Shares

$181,236
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

66.4K
Shares

$175,214
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

54.8K
Shares

$144,753
0.0% of portfolio

View Full List

About NEXGEL, INC.

Ticker NXGL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 5,572,230
Market Cap $14.7M
Description
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...

More about NXGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account